Co-Authors
This is a "connection" page, showing publications co-authored by Carolyn Calfee and B Thompson.
Connection Strength
0.560
-
Advancing precision medicine for acute respiratory distress syndrome. Lancet Respir Med. 2022 01; 10(1):107-120.
Score: 0.239
-
Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011 Apr; 39(4):711-7.
Score: 0.117
-
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020 12 01; 324(21):2165-2176.
Score: 0.057
-
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019 02; 7(2):154-162.
Score: 0.050
-
Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018 Nov; 44(11):1859-1869.
Score: 0.049
-
Stability of ARDS subphenotypes over time in two randomised controlled trials. Thorax. 2018 05; 73(5):439-445.
Score: 0.047